Tag Archives: blockbuster drug

Everything You Need to Know About Priority Review Vouchers: Part 2 of 2

The Rare Pediatric Disease PRV, the Difference in the PRVs, and the Future of the Program The Rare Pediatric Disease Priority Review Voucher (If you haven’t read Part 1 yet, start there first!) A new Priority Review Voucher (PRV) has … Continue reading

Posted in Clinical Trials, FDA, Regulatory Strategy | Tagged , , , , , , , , , | 1 Comment

Everything You Need to Know About Priority Review Vouchers: Part 1 of 2

The Basics, History, and Record of the Priority Review Voucher Program The Basics If your company’s goals include funding pipeline development or increasing speed to market you should, at least, be familiar with the concept of the Priority Review Voucher … Continue reading

Posted in Clinical Trials, FDA, Regulatory Strategy | Tagged , , , , , , , , , , | 1 Comment

The CED Life Science Conference and Biotech’s Yellow Brick Road

The 21st annual CED Life Science Conference achieved its mission of cementing the Research Triangle Park as a hotbed for innovation and opportunity in biotech.  The 2012 CED LSC showcased local leaders like Victor Dzau, President and CEO of Duke … Continue reading

Posted in Clinical Trials, Conferences and Meetings, FDA, Industry News, Regulatory Strategy | Tagged , , , , , , , , , , , , , , , , , , , | 1 Comment

Blockbuster Sales Forecasts for 2010 and 2014

The most reliable way to forecast the future is to try to understand the present. – John Naisbitt Interested in what blockbuster drug sales may be like for the next 4 years?  Trying to position your developing therapeutic against the … Continue reading

Posted in Industry News | Tagged , , , , , , , , , | Comments Off on Blockbuster Sales Forecasts for 2010 and 2014